期刊文献+

酮咯酸氨丁三醇预防瑞芬太尼全麻苏醒期疼痛及躁动临床效果观察 被引量:4

Clinical effects of ketorolac tromethamine on prevention of pain and agitation during anesthesia recovery period after remifentanil anesthesia
暂未订购
导出
摘要 目的:观察酮咯酸氨丁三醇预防瑞芬太尼全麻苏醒期疼痛及躁动的临床效果。方法:选择40~60岁择期行腹腔镜胆囊手术患者100例,ASA I~II级,随机分为两组,每组50例,观察组手术结束前30min静脉滴注酮咯酸氨丁三醇30mg,对照组手术结束前30min静脉滴0.9%氯化钠1mL,观察两组患者自主呼吸恢复时间、苏醒时问、拔管时间以及拔管后15、30min疼痛评分和烦躁程度评级。结果:两组自主呼吸恢复时间、苏醒时间、拔管时间差异均无统计学意义(P>0.05);观察组拔管后15、30min疼痛评分及躁动程度评级明显低于对照组,差异有统计学意义(P均<0.01)。结论:酮咯酸氨丁三醇可以预防瑞芬太尼全麻苏醒期疼痛和躁动。 Objective. To observe the clinical effects of ketorolac tromethamine for prevention of pain and agitation during anesthesia recovery period after remifentanil anesthesia. Method. A total of 100 cases scheduled for laparoscopic cholecystectomy aged between 40-60 years, categoried as ASA Ⅰ-Ⅱ stage, were randomly divided into two groups with 50 cases in each. 30 mg of ketorolac tromethamine was infused intravenously for experimental group 30 min before the end of the operation; 1 mL of 0.9% sodium chloride was given for the control group at the same time point. Spontaneous breathing recovery time, recovery time and extubation time were recorded. Pain score and agitation severity score were evaluated 15 and 30 min after extubation. Results. No significant differences were found in spontaneous respiratory recovery time, recovery time, extubation time between the two groups ( P〉0.05 ); the pain score and agi- tation severity score of the experimental group were both significantly higher than that in the control group ( P〈 0.01 ). Conclusions: Ketorolac tromethamine can prevent pain and agitation during anesthesia recovery period after remifentanil anesthesia.
出处 《海南医学院学报》 CAS 2012年第7期962-963,966,共3页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210242)~~
关键词 酮咯酸氨丁三醇 瑞芬太尼 疼痛 躁动 Ketorolac tromethamine Remifentanil Pain Agitation
  • 相关文献

参考文献4

二级参考文献24

  • 1陶昱斐,丁燕飞,刘琴,姚瑶.酮咯酸氨丁三醇微囊的研究[J].中南药学,2006,4(2):108-111. 被引量:5
  • 2李利华,裴奇,谢昭明,阳国平.高效液相色谱法测定酮咯酸氨丁三醇胶囊含量及含量均匀度[J].中南药学,2006,4(5):348-350. 被引量:12
  • 3Thompson JP, Rowbotham DJ. Remifentanil: an opioid for the 21st century. Br J Anaesth,1996, 76: 341-343.
  • 4Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterase. Anesth Analg, 1995, 81: 619-623.
  • 5Yarmush J, D'Angelo R, Kirkhart B, et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology, 1997, 87: 235-243.
  • 6Fletcher D, Pinaud M, Scherpereel P, et al. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg, 2000, 90: 666-671.
  • 7Kissin I, Lee KS, Arthur GR, et al. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg, 1996, 83: 600-605.
  • 8Kissin I, Brown PT, Bradley EL Jr. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology, 1991, 75: 813- 816.
  • 9Gardmark M, Ekblom M, Bouw R, et al. Quantification of effect delay and acute tolerance development to morphine in the rat. J Pharmacol Exp Ther, 1993, 267: 1061-1067.
  • 10Saito Y, Kaneko M, Kifihara Y, et al. Interaction of intrathecally infused morphine and lidocaine in rats (part Ⅱ ): effects on the development of tolerance to morphine. Anesthesiology, 1998. 89 : 1464- 1470.

共引文献157

同被引文献26

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部